Sotera Health (NASDAQ:SHC) Sees Strong Trading Volume

Sotera Health (NASDAQ:SHC) saw strong trading volume on Thursday . 1,991,893 shares were traded during trading, an increase of 53% from the previous session’s volume of 1,305,298 shares.The stock last traded at $16.15 and had previously closed at $15.41.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Barclays raised their price target on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Piper Sandler initiated coverage on Sotera Health in a research note on Tuesday, May 21st. They issued a “neutral” rating and a $13.00 price objective on the stock. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Tuesday, August 6th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Sotera Health has an average rating of “Moderate Buy” and an average price target of $15.70.

Sotera Health Trading Up 8.0 %

The company has a debt-to-equity ratio of 5.46, a quick ratio of 2.59 and a current ratio of 2.93. The company’s 50 day moving average is $13.75 and its 200 day moving average is $12.79. The stock has a market capitalization of $4.71 billion, a price-to-earnings ratio of 85.90 and a beta of 2.06.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Monday, August 5th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. The business had revenue of $277.00 million for the quarter, compared to analysts’ expectations of $266.45 million. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.19 earnings per share. On average, research analysts forecast that Sotera Health will post 0.64 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Janus Henderson Group PLC raised its position in shares of Sotera Health by 43.6% in the 1st quarter. Janus Henderson Group PLC now owns 14,892,868 shares of the company’s stock valued at $178,865,000 after acquiring an additional 4,525,056 shares during the period. Vanguard Group Inc. raised its holdings in Sotera Health by 27.0% during the 1st quarter. Vanguard Group Inc. now owns 12,145,110 shares of the company’s stock worth $145,863,000 after buying an additional 2,579,248 shares during the period. Sessa Capital IM L.P. grew its stake in shares of Sotera Health by 7.5% during the 2nd quarter. Sessa Capital IM L.P. now owns 4,300,597 shares of the company’s stock worth $51,048,000 after acquiring an additional 300,597 shares in the last quarter. Darsana Capital Partners LP bought a new position in shares of Sotera Health during the 2nd quarter worth approximately $29,074,000. Finally, P2 Capital Partners LLC grew its stake in shares of Sotera Health by 27.0% during the 4th quarter. P2 Capital Partners LLC now owns 2,350,000 shares of the company’s stock worth $39,598,000 after acquiring an additional 500,000 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.